| Literature DB >> 32698866 |
Hatem S Abd El-Hamid1, Manal E Shafi2, Najah M Albaqami2, Hany F Ellakany3, Naglaa M Abdelaziz4, Mohamed N Abdelaziz4, Mohamed E Abd El-Hack5, Ayman E Taha6, Khalid M Alanazi7, Ahmed R Elbestawy1.
Abstract
BACKGROUND: Newcastle disease (ND) causes severe economic losses in poultry industry worldwide. Egyptian poultry industry suffered from severe economic losses since the isolation of Velogenic Newcastle disease virus (vNDV) genotype VIId in 2011 and up till now despite the use of different vaccination programs. So, this study aimed to isolate and characterize the vNDV from a total of 120 poultry flocks from ten provinces in the Egyptian Delta region with a history of respiratory manifestation, high mortalities or a decrease in egg production between 2015 and 2019. Seventy-three samples' allantoic fluid (73/120, 60.8%) were positive for hemagglutination with chicken RBCs. These samples were submitted to molecular examination using qRT-PCR specific primers for AOAV-1, highly pathogenic avian influenza (HPAI-H5), low pathogenic avian influenza (LPAI-H9) and infectious bronchitis virus (IBV).Entities:
Keywords: Amino acid residue substitution; Avian Orthoavulavirus 1; F protein; Intracerebral; Sequencing
Mesh:
Substances:
Year: 2020 PMID: 32698866 PMCID: PMC7374864 DOI: 10.1186/s12917-020-02470-9
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
The HA, qRT-PCR confirmation of AOAV-1 with other viruses in the Egyptian provinces of Delta Region
| Province | Total samples / province | HA negative | HA positive | Total positive samples for examined viruses using qRT_PCR | ||||
|---|---|---|---|---|---|---|---|---|
| Positive AOAV-1/total samples of each province | H5 positive samples | H9 positive samples | IBV | |||||
| Total Samples 120 | El Behiera | 63 | 26 | 37 | 26/63: 41.2% | 0 | 11 | 2 |
| Alexandria | 13 | 3 | 10 | 4/13: 30.7% | 0 | 4 | 1 | |
| El Gharbia | 15 | 7 | 8 | 8/15: 53.3% | 1 | 0 | 0 | |
| El Qaliobia | 9 | 5 | 4 | 2/9: 22.2% | 0 | 0 | – | |
| El Dakahlia | 7 | 3 | 4 | 3/7: 42.8% | 0 | 0 | – | |
| Kafr El Shiekh | 3 | 1 | 2 | 2/3: 66.6% | 0 | 0 | – | |
| EL Menofia | 3 | 1 | 2 | 2/3: 66.6% | 0 | 0 | – | |
| El Giza | 3 | 0 | 3 | 0/0: 0% | 1 | 2 | 1 | |
| Marsa Mattrouh | 2 | 1 | 1 | 1/2: 50% | 0 | 0 | – | |
| El Sharkia | 2 | 0 | 2 | 1/2: 50% | 0 | 0 | 1 | |
| Total | 10 | 120 | 47 | 73 | 50/120: 41.6% | 2/120: 1.6% | 17/120: 14.1% | 5/120: 4.1% |
ND + H9: 2; ND + H5: 1; ND + IB: 2; ND + H9 + IB: 1 and 7 haemagglutinating samples were negative for all examined viruses
Intra-cerebral Pathogenicity Testing for 10 selected AOAV-1 isolates and molecular, genetic pathotyping and accession numbers of all 16 (full and partial F gene sequenced AOAV-1)
| Strain code | Province | Type of bird /age | Year of isolation | ICPI value | pathotype | Virulence | Genotyping | Accession number |
|---|---|---|---|---|---|---|---|---|
| 1 | El Behiera | Broiler | 2015 | n.d. | Velogenic | 112RRQKRF117 | VII.1.1 | MH445410 |
| 2 | 2016 | 1.83 | MK984289 | |||||
| 3 | 2017 | 1.75 | MN519688 | |||||
| 4 | 1.83 | MK984236 | ||||||
| 5 | Broilers | 2018 | 1.98 | MK984237 | ||||
| 6 | Alexandria | 1.92 | MN519690 | |||||
| 7 | El Dakahlia | 1.87 | MN519692 | |||||
| 8 | Marsa Mattrouh | 1.70 | MN519696 | |||||
| 9 | El Sharkia | 1.75 | MN519693 | |||||
| 10 | El Behiera | 1.86 | MK984238 | |||||
| 11 | El Gharbia | Layer pullets | 1.71 | MN519689 | ||||
| 12 | Kafer Elshiekh | Layers | n.d. | MN519694 | ||||
| 13 | El Qaliobia | Broilers | n.d. | MN519687 | ||||
| 14 | Alexandria | Pigeons | n.d. | MN519685 | ||||
| 15 | n.d. | MN519686 | ||||||
| 16 | El Behiera | Broilers | 2019 | n.d. | MN519684 |
Abbreviation: n.d. not done
Amino acids substitutions in function domain of F protein
| ID Fusion F0 protein | Signal peptide | Fusion F2 subunit | Fusion F1 subunit (117–533) aa | ||||||
|---|---|---|---|---|---|---|---|---|---|
| (32–111aa) | Cleavage site CS aa (112–117) | Fusion peptides | Heptad repeat HRa | Heptad repeat HRb (268–299) aa | Heptad repeat HRc (471–500) aa | Transmembrane TM (501–522) aa | Cytoplasmic tail CT (523–553) aa | ||
| 30S | 78R | 112–117aa | – | 152 L, | – | 479D | 505I, 517 L | 531A, 541 N, 546Q | |
MN519684 (AOAV-Eg-Ch-MN51–2019, F, Complete) | S | R | RRQKRF | – | – | – | 479G | – | – |
MK984236 (AOAV1-Eg-Ch-B36–2017, F, Complete) | N | R | RRQKRF | – | - 170 N | – | – | – | – |
MK984237 (AOAV1-Eg-Ch-D30–2018, F, Complete) | N | R | RRQKRF | – | – | – | – | – | – |
MK984239 (AOAV-Eg-Ch-F2–2016, F, Complete) | S | K | RRQKRF | – | 152H - | – | – | – | – |
MK984238 (AOAV1-Eg-Ch-R78–2018, F, Complete) | N | R | RRQKRF | – | - 170 N | – | – | – | 546H |
MH445410.1 (AOAV1-Eg-Ch-18-2015, F, Complete) | S | R | RRQKRF | – | – | – | – | 505 M, 517F | 531 T, 541I |
Fig. 1Alignment of deduced amino acid of full fusion protein of 6 isolates under study and consensus reference, Egyptian and vaccinal strains. SP = signal peptide, CS = Cleavage site, FP = Fusion Peptides, HR = Heptad repeats (a,b,c),TM = transmembrane domain, CT = cytoplasmic tail, the arrow refers to the neutralizing epitopes and strip refers to 6 glycosylation sites
Fig. 23D structural of fusion protein of AOAV-I VII.1.1 by Paymol
Fig. 3Sequence logo (SeqLogo) generated from amino acid sequence alignment which is a useful tool to visualize sequence patterns and represent a more informative alternative to consensus sequence
Fig. 4Phylogenetic tree involved nucleotide sequence represent all genotypes of AOAV-1 (From I to XXI) and branch red color represent Genotype VII and the 6 isolates arranged with genotype VII. evolutionary analysis by Maximum Likelihood method. This analysis involved 127 nucleotide sequences. There were a total of 1659 positions in the final dataset
Fig. 5Evolutionary analysis by Maximum Likelihood method. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. This analysis involved 118 nucleotide sequences. Codon positions included were 1st, 2nd, 3rd, noncoding. There were a total of 1660 positions in the final dataset. Red solids refer to 6 isolates of the study
Fig. 6Nucleotide identity and divergence percent between 6 AOAV-1 genotypes VII.1.1 and consensus global, Egyptian and vaccine strains
Sources of collected samples during 2016–2019
| Total samples | Sample origin /(number) | Samples host /(number) | Types of Samples | Mortality within 1 week before sampling |
|---|---|---|---|---|
| 120 from 10 provinces | El Behiera / (63) Alexandria/ (13) El Gharbia/ (15) El Qaliobia / (9) El Dakahlia / (7) Kafer El-Shiekh / (3) El Monofia / (3) El Giza/ (3) Marsa Mattrouh / (2) El Sharkia / (2) | Broiler / (90) Layers/ (13) Balady chickens/ (7) Pigeon / (4) Broiler Breeders / (3) Saso / (3) | Organs (trachea, lung, spleen, liver. Kidney, cecal tonsils) Brain (in case of nervous signs). Swabs (tracheal & cloacal) | 10–35% |